Widely used:Recently Viewed
Clear All
Value Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹24,254 Cr
P/E Ratio
76.98
P/B Ratio
9.07
Industry P/E
--
Debt to Equity
0.12
ROE
19.09 %
ROCE
23.63 %
Div. Yield
0.13 %
Book Value
263.98
EPS
31.88
CFO
₹1,191.65 Cr
EBITDA
₹1,746.00 Cr
Net Profit
₹1,116.04 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Poly Medicure
| -8.48 | 8.10 | -3.48 | 52.61 | 38.45 | 57.58 | 24.48 |
|
BSE Healthcare
| -7.68 | 6.11 | -2.04 | 19.11 | 18.77 | 22.70 | 8.84 |
|
BSE Mid Cap
| -9.50 | 7.47 | -4.03 | 4.13 | 18.88 | 29.38 | 14.34 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Poly Medicure
| 77.95 | 65.94 | -6.27 | 88.07 | 132.90 | -2.44 | -20.37 |
|
BSE Mid Cap
| 25.84 | 45.53 | 1.38 | 39.18 | 19.87 | -3.05 | -13.31 |
|
BSE Healthcare
| 43.09 | 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 157.00 | 86.51 | 15.49 | 17.64 | |
| 248.16 | 235.70 | -- | -2.98 | |
| 101.00 | 180.29 | 20.27 | 10.98 | |
| 68.80 | 90.90 | 27.14 | 20.11 |
1 min read•By Research Desk
Poly Medicure Limited manufactures and sells medical devices in India and internationally. It offers infusion devices, such as I.V. cannulas, mid line catheters, arterial cannula, three way stop cocks, I.V. infusion sets, manifolds, safety winged... infusion sets, T-type extension sets, stylet/mandrin with luer locks, vial access spikes, measured volume fluid administration sets, extension lines, central venous catheters, CVP manometers, needle free connectors, pre filled syringes, vascular accesses, and blood administration sets. The company also provides nasogastric and infant feeding tubes, gastro-duodenal feeding tubes, and umbilical catheters; urine collection bags, foley balloon catheters, irrigation sets, urine drainage catheters, and urine collection bags with measured volume meters; and endotracheal and tracheostomy tubes, mucus extractors, ventilator circuits, bain circuits, catheter mounts, spinal needles, HME filters, and laryngeal mask airways. It offers oncology products; endo bronchial suction catheters, oxygen catheters, respiratory exercisers, nasal oxygen cannulas, oro-pharyngeal airways, variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, and aerosol therapy masks; and dialyzers, blood lines, dialysis systems, fistula needles, haemodialysis catheters, and peritoneal dialysis and transfusion sets. The company provides closed wound suction units, under water seal drainage systems, high pressure vacuum bottles, yankauer suction sets, and thoracic drainage catheters; blood collection tubes, safety blood collection sets, blood collection needles, ESR pipettes, and luer adaptors; blood bag systems; face protective shields, polymasks, and viral transport medium kits; and insulin syringes, sputum collectors, dry brushes, umbilical cord clamps, luer locks, cannula fixators, injection stoppers, luer lock injection sites, universal caps, and ECG electrodes. The company was incorporated in 1995 and is based in New Delhi, India. Read more
Incorporated
1995
Chairman
Devendra Raj Mehta
Managing Director
Himanshu Baid
Headquarters
New Delhi, Delhi
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Poly Medicure Ltd stood at ₹ 3,052 Cr as on 31-Dec-24
The share price of Poly Medicure Ltd is ₹2,393.50 (NSE) and ₹2,393.70 (BSE) as of 17-Apr-2025 IST. Poly Medicure Ltd has given a return of 38.45% in the last 3 years.
Poly Medicure Ltd has a market capitalisation of ₹ 24,254 Cr as on 17-Apr-2025. As per Value Research classification, it is a Mid Cap company.
The P/B ratio of Poly Medicure Ltd is 9.07 times as on 17-Apr-2025, a 637% premium to its peers’ median range of 1.23 times.
The P/E ratio of Poly Medicure Ltd is 76.98 times as on 17-Apr-2025.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Poly Medicure Ltd and enter the required number of quantities and click on buy to purchase the shares of Poly Medicure Ltd.
Poly Medicure Limited manufactures and sells medical devices in India and internationally. It offers infusion devices, such as I.V. cannulas, mid line catheters, arterial cannula, three way stop cocks, I.V. infusion sets, manifolds, safety winged infusion sets, T-type extension sets, stylet/mandrin with luer locks, vial access spikes, measured volume fluid administration sets, extension lines, central venous catheters, CVP manometers, needle free connectors, pre filled syringes, vascular accesses, and blood administration sets. The company also provides nasogastric and infant feeding tubes, gastro-duodenal feeding tubes, and umbilical catheters; urine collection bags, foley balloon catheters, irrigation sets, urine drainage catheters, and urine collection bags with measured volume meters; and endotracheal and tracheostomy tubes, mucus extractors, ventilator circuits, bain circuits, catheter mounts, spinal needles, HME filters, and laryngeal mask airways. It offers oncology products; endo bronchial suction catheters, oxygen catheters, respiratory exercisers, nasal oxygen cannulas, oro-pharyngeal airways, variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, and aerosol therapy masks; and dialyzers, blood lines, dialysis systems, fistula needles, haemodialysis catheters, and peritoneal dialysis and transfusion sets. The company provides closed wound suction units, under water seal drainage systems, high pressure vacuum bottles, yankauer suction sets, and thoracic drainage catheters; blood collection tubes, safety blood collection sets, blood collection needles, ESR pipettes, and luer adaptors; blood bag systems; face protective shields, polymasks, and viral transport medium kits; and insulin syringes, sputum collectors, dry brushes, umbilical cord clamps, luer locks, cannula fixators, injection stoppers, luer lock injection sites, universal caps, and ECG electrodes. The company was incorporated in 1995 and is based in New Delhi, India.
The prominent promoters of Poly Medicure Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
EZEKIEL GLOBAL BUSINESS SOLUTIONS LLP |
12.2%
|
|
RISHI BAID |
9.59%
|
|
ZETTA MATRIX CONSULTING LLP |
8.21%
|
|
HIMANSHU BAID |
7.8%
|
|
HIMANSHU BAID (HUF) |
3.79%
|
The chairman of the company is Devendra Raj Mehta, and the managing director is Himanshu Baid.
There is no promoter pledging in Poly Medicure Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
214
|
|
|
193
|
|
|
93
|
|
|
85
|
| Poly Medicure Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
15.52
|
|
Operating margin(%)
|
21.91
|
|
Net Margin(%)
|
18.49
|
|
Dividend yield(%)
|
0.13
|
Yes, TTM profit after tax of Poly Medicure Ltd was ₹315 Cr.
₹73.10
(
